New Horizons in Covid-19 Drugs & Vaccines Research & Development

SARS-CoV-2 mechanisms of severe outcomes

Baricitinib as a potential drug for COVID-19: evidence from a multicenter trial and translational research studies

Allosteric site of SARS-CoV-2 main protease as drug target in the presence of its emerging mutations

Lessons learned from animal models of COVID-19

Bioengineering tools to speed up the discovery and preclinical testing of vaccines for SARS-CoV-2 and therapeutic agents for COVID-19

Innovative Therapeutic Interventions for SARS-CoV-2 – exploiting metabolic synergy

Internet Knowledge Mining tools and A.I. For Rapid Response to New Pandemics with Proposals for Synthetic Vaccines and Therapeutics. The Example of COVID19

Screening Possible Drug Molecules for Covid-19: A Computational Study based on Docking Studies & Molecular Dynamics to Design New Inhibitor Candidates

Vesicular stomatitis virus vectored vaccine for SARS-CoV-2

In silico drug discovery for COVID-19 using gene expression profiles of mouse infected by MHV and those of human cell lines infected by SARS-CoV-2

Machine learning analysis of single-cell gene regulatory networks reveals potential mechanisms of action of antimalarials against SARS-CoV-2

The Clinically Validated Viral Superinfection Therapy (SIT) Platform Technology May Mitigate Severe Cases of COVID-19 Infections

Vaccine and Drug Designing for COVID-19- Research and Prevention Strategies